Search

Search Constraints

You searched for: Author/Creator Foster, Meredith C.

Search Results

1. Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results. Issue 9 (11th July 2021)

3. Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA‐MM subgroup analysis. Issue 11 (23rd September 2021)

4. Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial. Issue 1 (26th October 2018)

5. Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials. Issue 1 (18th October 2020)